Time to administer polymyxin B hemoperfusion and hemodynamics in patients with septic shock requiring high-dose norepinephrine: a predetermined analysis of a prospective cohort study

In patients with septic shock, early administration of PMX-HP was associated with higher mean arterial pressure and lower VIS within 48 h after ICU admission. Additionally, it may be associated with an improved clinical course, represented by more ICU-free and vasopressor/inotrope-free days. Trial registration UMIN Clinical Trial Registry on 1 November 2019 (registration no. UMIN000038302).

Authors

Institutions

Publication Details

Journal
Critical Care
Published
2025-05-09
DOI
https://doi.org/10.1186/s13054-025-05422-7
Citations
4
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time to administer polymyxin B hemoperfusion and hemodynamics in patients with septic shock requiring high-dose norepinephrine: a predetermined analysis of a prospective cohort study

Tsuyoshi Suzuki, Kazunori Fukushima, Kyohei Miyamoto, Minori Kinjo et al.
4 citations
Critical Care
Sepsis Diagnosis and Treatment
5.42
article

Time to administer polymyxin B hemoperfusion and hemodynamics in patients with septic shock requiring high-dose norepinephrine: a predetermined analysis of a prospective cohort study

Tsuyoshi Suzuki, Kazunori Fukushima, Kyohei Miyamoto, Minori Kinjo, Yu Kawazoe, Tasuku Hanajima, Tetsuya Sato, Jun‐ichi Maruyama, Satoru Murata, Michihito Kyo, Yukitoshi Toyoda, Takeshi Morimoto, Noriko Miyagawa, Tomoya Okazaki, Takuya Kimura, Hiroshi Matsuura, Hitoshi Yamamura, Toshihiro Sakurai, Gaku Takahashi, Masaki Takahashi, Yoshinori Ohta
article en
4 citations

Abstract

In patients with septic shock, early administration of PMX-HP was associated with higher mean arterial pressure and lower VIS within 48 h after ICU admission. Additionally, it may be associated with an improved clinical course, represented by more ICU-free and vasopressor/inotrope-free days. Trial registration UMIN Clinical Trial Registry on 1 November 2019 (registration no. UMIN000038302).

Critical CareVol. 29(1)
Hiroshima University (JP), Fukushima Medical University (JP), Gunma University (JP), Iwate Medical University (JP), Hokkaido University (JP), Kyoto Medical Center (JP), Fukuoka University Hospital (JP), Tohoku University Hospital (JP), Sendai Medical Center (JP), Saiseikai Utsunomiya hospital (JP), Osaka Hospital (JP), Shizuoka General Hospital (JP), Kagawa University Hospital (JP), National Hospital Organization (JP), Kumamoto Medical Center (JP), Ehime University (JP), Nara Prefecture General Medical Center (JP), Nara Medical University (JP), Hyogo University (JP)
Wakayama Medical University, Toray Industries
Good health and well-being
Openalex Percentile: Top 4%
Sepsis Diagnosis and Treatment
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.